Stem Cell Medical Reports for: Muscular Dystrophy
Author or authors of report : Stefano Biressi, Antonio Filareto, Thomas A. Rando
Date of report : 2020-10-12
Muscular Dystrophy
Abstract: Muscular dystrophies are a diverse group of genetic diseases marked by progressive degeneration of skeletal and cardiac muscle. Despite extensive research into various therapeutic options, no definitive treatment has
Author or authors of report : Alok Sharma, Hemangi Sane, Prerna Badhe, Nandini Gokulchandran, Pooja Kulkarni, Mamta Lohiya, Hema Biju, V C Jacob
Date of report : 2013-09-10
Muscular Dystrophy
  Major Points: No Adverse Events: The study reported no significant adverse events, indicating the safety of the treatment. Neurological Improvements: Post-transplantation assessments showed improvements in trunk muscle strength, limb
Author or authors of report : Alper Dai, Osman Baspinar, Ahmet Yeşilyurt, Eda Sun, Çiğdem İnci Aydemir, Olga Nehir Öztel, Davut Unsal Capkan, Ferda Pinarli, Abdullah Agar, Erdal Karaöz
Date of report : 2018-10-26
Muscular Dystrophy
  Major Points and Findings: Purpose: The study aimed to investigate the effects of allogeneic Wharton jelly-derived mesenchymal stem cells (WJ-MSCs) therapy in children with Duchenne muscular dystrophy (DMD). DMD
Author or authors of report : Dorota Sienkiewicz, Wojciech Kulak, Bożena Okurowska-Zawada, Grażyna Paszko-Patej, Katarzyna Kawnik
Date of report : 2015-07-08
Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD) Overview: DMD is the most commonly inherited pediatric muscle disorder. It is an X-linked genetic progressive and degenerative myopathy characterized by muscle wasting and weakness. This
Author or authors of report : Kenji Rowel Q Lim, Rika Maruyama, Toshifumi Yokota,
Date of report : 2017-02-28
Muscular Dystrophy
Summary of Medical Report on Eteplirsen for Duchenne Muscular Dystrophy The medical report titled "Eteplirsen in the treatment of Duchenne muscular dystrophy" focuses on the efficacy, safety, and pharmacology of
Author or authors of report : Nertiyan Elangkovan, George Dickson
Date of report : 2021-11-30
Muscular Dystrophy
  Introduction to Duchenne Muscular Dystrophy (DMD) DMD is an X-linked muscle-wasting disease affecting 1 in 5000 males. Affected individuals typically become wheelchair-bound by the age of twelve and often
Author or authors of report : Prof David J Birnkrant, Prof Katharine Bushby, Carla M Bann, Prof Susan D Apkon, Angela Blackwell, David Brumbaugh, Laura E Case, Prof Paula R Clemens, Stasia Hadjiyannakis, Shree Pandya, Natalie Street, Jean Tomezsko, Prof Kathryn R Wagner, Leanne M Ward
Date of report : 2018-02-03
Muscular Dystrophy
  Major Points: Introduction to DMD: Duchenne muscular dystrophy is a lethal X-linked recessive neuromuscular disorder caused by mutations in the dystrophin gene. It leads to progressive muscular damage, degeneration,
Author or authors of report : Maria Sofia Falzarano, Chiara Scotton, Chiara Passarelli, Alessandra Ferlini, Alessandra Ferlini,
Date of report : 2015-10-07
Muscular Dystrophy
  Introduction to DMD Duchenne muscular dystrophy (DMD) is an X-linked inherited neuromuscular disorder resulting from mutations in the dystrophin gene. The absence of the dystrophin protein leads to degeneration